Bronchopulmonary dysplasia: "a vascular hypothesis".
Abman
S H
SH
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D001997:Bronchopulmonary Dysplasia / Q000196:embryology* / Q000209:etiology* / Q000378:metabolism / Q000401:mortality / Q000473:pathology / Q000628:therapy; D016228:Endothelial Growth Factors / Q000032:analysis / Q000502:physiology; D018507:Gene Expression Regulation, Developmental / Q000502:physiology; D006801:Humans; D007211:Indoles / Q000627:therapeutic use; D007231:Infant, Newborn; D008222:Lymphokines / Q000032:analysis / Q000187:drug effects / Q000502:physiology; D011518:Proto-Oncogene Proteins / Q000032:analysis / Q000187:drug effects / Q000502:physiology; D011758:Pyrroles / Q000627:therapeutic use; D020794:Receptor Protein-Tyrosine Kinases / Q000032:analysis / Q000187:drug effects / Q000502:physiology; D012121:Respiration, Artificial / Q000009:adverse effects; D012127:Respiratory Distress Syndrome, Newborn / Q000150:complications / Q000628:therapy; D012307:Risk Factors; D015398:Signal Transduction / Q000502:physiology; D042461:Vascular Endothelial Growth Factor A; D040281:Vascular Endothelial Growth Factor Receptor-1; D042442:Vascular Endothelial Growth Factors
D020533:Angiogenesis Inhibitors; D016228:Endothelial Growth Factors; D007211:Indoles; D008222:Lymphokines; D011518:Proto-Oncogene Proteins; D011758:Pyrroles; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; C116890:Semaxinib; D020794:Receptor Protein-Tyrosine Kinases; D040281:Vascular Endothelial Growth Factor Receptor-1